AstraZeneca Expands Cancer Work With €62.6M Innate Stake

By Darcy Reddan
October 23, 2018, 4:42 PM EDT

Pharmaceutical and biopharmaceutical company AstraZeneca PLC said on Tuesday that it has acquired a 9.8 percent equity stake in Innate Pharma for €62.6 million ($71.8 million)....

Already a subscriber? Click here to view full article